PSMB7 Protein

PSMB7 Protein — Proteasome Subunit Beta Type-7

Introduction

Psmb7 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein">
<div class="infobox-header">PSMB7</div>
<table>
<tr><th>Full Name</th><td>Proteasome Subunit Beta Type-7</td></tr>
<tr><th>Gene</th><td>[PSMB7](/genes/psmb7)</td></tr>
<tr><th>UniProt ID</th><td>[Q9Y242](https://www.uniprot.org/uniprot/Q9Y242)</td></tr>
<tr><th>PDB ID</th><td>[5MX3](https://www.ebi.ac.uk/pdbe/5MX3)</td></tr>
<tr><th>Molecular Weight</th><td>30.2 kDa</td></tr>
<tr><th>EC Number</th><td>3.4.25.1</td></tr>
<tr><th>Subcellular Localization</th><td>Cytoplasm, Nucleus</td></tr>
<tr><th>Protein Family</th><td>Proteasome beta subunit family</td></tr>
<tr><th>Aliases</th><td>Z, LMP7, LMP7</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">8 edges</a></td>
</tr>
</table>
</div>

Overview

...

PSMB7 Protein — Proteasome Subunit Beta Type-7

Introduction

Psmb7 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein">
<div class="infobox-header">PSMB7</div>
<table>
<tr><th>Full Name</th><td>Proteasome Subunit Beta Type-7</td></tr>
<tr><th>Gene</th><td>[PSMB7](/genes/psmb7)</td></tr>
<tr><th>UniProt ID</th><td>[Q9Y242](https://www.uniprot.org/uniprot/Q9Y242)</td></tr>
<tr><th>PDB ID</th><td>[5MX3](https://www.ebi.ac.uk/pdbe/5MX3)</td></tr>
<tr><th>Molecular Weight</th><td>30.2 kDa</td></tr>
<tr><th>EC Number</th><td>3.4.25.1</td></tr>
<tr><th>Subcellular Localization</th><td>Cytoplasm, Nucleus</td></tr>
<tr><th>Protein Family</th><td>Proteasome beta subunit family</td></tr>
<tr><th>Aliases</th><td>Z, LMP7, LMP7</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">8 edges</a></td>
</tr>
</table>
</div>

Overview

PSMB7 (Proteasome Subunit Beta Type-7), also known as LMP7, is the chymotrypsin-like catalytic subunit of the 20S proteasome[@kim2021]. PSMB7 is the major proteolytic activity of the proteasome, responsible for cleaving hydrophobic residues, which is crucial for protein degradation and cellular homeostasis. It is constitutively expressed but can be induced by interferon-γ in immune cells[@groettrup2020].

PSMB7 is essential for normal proteasome function and is particularly important in immune cells where it participates in antigen processing and presentation via the MHC class I pathway. It is also critical in [neurons](/entities/neurons) for maintaining proteostasis and clearing damaged proteins[@dikic2022].

Structure

Primary Structure

• Amino acids: 277 residues
• Molecular weight: 30.2 kDa
• N-terminal threonine: Catalytic residue (Thr1)
• Signal peptide: Cleaved in immune cells for inducible expression

Three-Dimensional Structure

PSMB7 adopts the classic proteasome β-subunit fold:

• N-terminal domain: Catalytic β-propeller with Thr1
• C-terminal domain: Supporting α-helical bundle
• Active site: Thr1-OH nucleophile for proteolysis

Subunit Position

In the 20S proteasome:

• Outer α-rings: PSMA1-7 (gate formation)
• Inner β-rings: β1(PSMB6)-β2(PSMB2)-β3(PSMB3)-β4(PSMB4)-β5(PSMB5)-β6(PSMB7)-β7(PSMB1)
• PSMB7 occupies the β5 position in the inner ring

Biological Function

Proteolytic Activity

PSMB7 provides chymotrypsin-like activity:

• Cleavage specificity: After hydrophobic residues (Phe, Leu, Tyr, Trp)
• Rate-limiting step: This activity is typically rate-limiting for proteolysis
• Substrates: Most cellular proteins, especially hydrophobic patches

Immune Function

Antigen processing: Generates peptides for MHC class I

Immunoproteasome: Induced form in immune cells (LMP7)

Cytokine production: Affects inflammatory responses

T-cell function: Essential for adaptive immunity

Role in Neurons

• Protein quality control: Degrades misfolded proteins
• Synaptic function: Regulates synaptic protein levels
• Stress response: Clears damaged proteins

Role in Neurodegeneration

Alzheimer's Disease

• Proteasome inhibition: [Aβ](/proteins/amyloid-beta) directly inhibits PSMB7 activity
• [Tau](/proteins/tau) clearance: Reduced chymotrypsin-like activity impairs tau degradation
• Synaptic loss: Proteasome dysfunction contributes to synaptic impairment
• Therapeutic target: Proteasome activators may benefit AD[@oddo2022]

Parkinson's Disease

• [α-synuclein](/proteins/alpha-synuclein) degradation: PSMB7 degrades α-syn monomers
• Dopaminergic neurons: SNc neurons particularly vulnerable
• LRRK2 mutations: Affect proteasome function
• Aggregate formation: Impaired clearance leads to inclusions

ALS

• [TDP-43](/mechanisms/tdp-43-proteinopathy) pathology: Proteasome impairment in motor neurons
• SOD1 mutants: Proteasome stress
• [C9orf72](/entities/c9orf72): Dipeptide repeats inhibit proteasome

Huntington's Disease

• Mutant [huntingtin](/proteins/huntingtin): Impairs proteasome function
• Transcriptional effects: Alters gene expression
• Therapeutic potential: Proteasome activation strategies

Therapeutic Implications

Drug Development

Proteasome activators: Overcome inhibition

Immunoproteasome inhibitors: For autoimmune conditions

Neuroprotective compounds: Enhance neuronal proteostasis

Research Tools

• Activity probes: Measure PSMB7 activity in situ
• Inhibitors: Carfilzomib, bortezomib (cancer therapy)
• Knockout models: PSMB7-deficient mice

Cross-Links

• [PSMB7 Gene](/genes/psmb7) — Gene page
• [Proteasome](/mechanisms/ubiquitin-proteasome-system) — [UPS](/mechanisms/ubiquitin-proteasome-system)
• [Alzheimer's Disease](/diseases/alzheimers-disease) — AD
• [Parkinson's Disease](/diseases/parkinsons-disease) — PD

Background

The study of Psmb7 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• [Proteasome in Neurodegeneration](/mechanisms/ubiquitin-proteasome-system)
• [Protein Aggregation](/mechanisms/protein-aggregation-neurodegeneration)
• [Ubiquitin-Proteasome System](/mechanisms/ubiquitin-proteasome-system)

External Links

• [UniProt](https://www.uniprot.org/)
• [NCBI Protein Database](https://www.ncbi.nlm.nih.gov/protein/)

References

[Kim HM, et al, Structure of the human 20S proteasome (2021)](https://doi.org/10.1016/j.jmb.2021.166746)

[Groettrup M, et al, The immunoproteasome and LMP7: From immunology to therapeutic perspectives (2020)](https://doi.org/10.1038/s41577-020-0346-x)

[Dikic I, et al, The ubiquitin-proteasome system and its role in neurodegeneration (2022)](https://doi.org/10.1016/j.neuron.2022.06.022)

[Oddo S, The ubiquitin-proteasome system in Alzheimer's disease (2022)](https://doi.org/10.1111/j.1582-4934.2008.00304.x)